Eurofins Scientific
Eurofins Scientific
ERF
EURONEXT
50.04
EUR
-0.79%
About
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 335.8K |
| Three Month Average Volume | 9.9M |
| High Low | |
| Fifty-Two Week High | 62.1 EUR |
| Fifty-Two Week Low | 39.47 EUR |
| Fifty-Two Week High Date | 10 Apr 2024 |
| Fifty-Two Week Low Date | 24 Jun 2024 |
| Price and Volume | |
| Current Price | 51.18 EUR |
| Beta | 0 |
| Relative Price Change | |
| Four Week Relative Price Change | -10.02% |
| Thirteen Week Relative Price Change | -3.92% |
| Twenty-Six Week Relative Price Change | -3.52% |
| Fifty-Two Week Relative Price Change | -13.77% |
| Year-to-Date Relative Price Change | -14.40% |
| Price Change | |
| One Day Price Change | -0.89% |
| Thirteen Week Price Change | -8.15% |
| Twenty-Six Week Price Change | -7.28% |
| Five Day Price Change | -1.80% |
| Fifty-Two Week Price Change | -9.64% |
| Year-to-Date Price Change | -13.22% |
| Month-to-Date Price Change | -0.89% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 26.44182 EUR |
| Book Value Per Share (Most Recent Quarter) | 27.39674 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | -1.40554 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | -1.60684 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 8.05092 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 32.91865 EUR |
| Revenue Per Share (Trailing Twelve Months) | 34.23523 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 0.5 EUR |
| Dividend Per Share (Trailing Twelve Months) | 0.5 EUR |
| Dividend Per Share (5 Year) | 0.636 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 2.6099 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | 2.93331 EUR |
| Normalized (Last Fiscal Year) | 2.91309 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 2.67755 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 2.98522 EUR |
| Including Extraordinary Items (Last Fiscal Year) | 1.29611 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | 1.66136 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 6.35958 EUR |
| Cash Per Share (Most Recent Quarter) | 3.55961 EUR |
| Cash Flow Per Share (Last Fiscal Year) | 5.7236 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | 6.16904 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | 2.45367 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 8 |
| Cash Flow Revenue (Trailing Twelve Months) | 7 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 11.96% |
| Pretax Margin (Last Fiscal Year) | 11.30% |
| Pretax Margin (5 Year) | 14.71% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 20.93% |
| Gross Margin (Trailing Twelve Months) | 22.02% |
| Gross Margin (5 Year) | 23.78% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 12.92% |
| Operating Margin (Trailing Twelve Months) | 14.02% |
| Operating Margin (5 Year) | 16.52% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 8.71% |
| Net Profit Margin (Trailing Twelve Months) | 9.32% |
| Net Profit Margin (5 Year) | 11.23% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 11.95% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 15.07% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 6.52% |
| Revenue Growth (3 Year) | 11.49% |
| Revenue Change (Trailing Twelve Months) | 3.28% |
| Revenue Per Share Growth | 9.76% |
| Revenue Growth (5 Year) | 6.20% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 8.58% |
| Total Debt (5 Year) | 4.46% |
| Dividends | |
| Dividend Growth (3 Year) | -9.74% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 27.25% |
| EPS Change (Trailing Twelve Months) | 13.11% |
| EPS Growth (3 Year) | 9.19% |
| EPS Growth (5 Year) | -8.71% |
| EBITDA | |
| EBITDA (5 Year) | 12.54% |
| EBITDA (5 Year Interim) | 13.32% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -1.54% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 36 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 20 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 2.9B |
| Net Debt (Last Fiscal Year) | 2.7B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 2 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 17 |
| PE Normalized (Last Fiscal Year) | 18 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 16 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 30 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 16 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 31 |
| Dividends | |
| Dividend Yield (5 Year) | 0.90% |
| Dividend Yield | 0.98% |
| Current Dividend Yield | 0.98% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 2 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 65 |
| Long Term Debt to Equity (Most Recent Quarter) | 64 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 37.31% |
| Payout Ratio (Trailing Twelve Months) | 33.45% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 32 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 27 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 276.0M |
| Free Cash Flow (Trailing Twelve Months) | 481.9M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 8 |
| Net Interest Coverage (Trailing Twelve Months) | 7 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 77 |
| Total Debt to Equity (Most Recent Quarter) | 68 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 5.41% |
| Return on Assets (Trailing Twelve Months) | 5.94% |
| Return on Assets (5 Year) | 7.49% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 10.48% |
| Return on Equity (Trailing Twelve Months) | 11.25% |
| Return on Equity (5 Year) | 15.96% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 6.70% |
| Return on Investment (Trailing Twelve Months) | 7.22% |
| Return on Investment (5 Year) | 9.36% |